Roosevelt Institute: The High Cost of Shareholder Power in Big Pharma
June 19, 2019
June 19, 2019
NEW YORK, June 19 -- Roosevelt Institute issued the following news release:
At a time when Americans pay record prices for medications, pharmaceutical companies generate record profits devoted largely to rewarding shareholders and pharma executives. Highlighting how these profits could go toward lowering the inflated costs of life-saving drugs, today the Roosevelt Institute released "Profit over Patients: Americans are Paying for a Financialized Pharmaceutical Industry" by . . .
At a time when Americans pay record prices for medications, pharmaceutical companies generate record profits devoted largely to rewarding shareholders and pharma executives. Highlighting how these profits could go toward lowering the inflated costs of life-saving drugs, today the Roosevelt Institute released "Profit over Patients: Americans are Paying for a Financialized Pharmaceutical Industry" by . . .